相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload
Moritz Schnelle et al.
CARDIOVASCULAR RESEARCH (2021)
Inhibition of SGLT1 protects against glycemic variability-induced cardiac damage and pyroptosis of cardiomyocytes in diabetic mice
Zhenjie Sun et al.
LIFE SCIENCES (2021)
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload
Milton Packer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Myocardial work index: a marker of left ventricular contractility in pressure-induced or volume overload-induced heart failure
Balint Karoly Lakatos et al.
ESC HEART FAILURE (2021)
SGLT1 Knockdown Attenuates Cardiac Fibroblast Activation in Diabetic Cardiac Fibrosis
Hui Lin et al.
FRONTIERS IN PHARMACOLOGY (2021)
Pretreatment with KGA-2727, a selective SGLT1 inhibitor, is protective against myocardial infarction-induced ventricular remodeling and heart failure in mice
Yohei Sawa et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2020)
Longitudinal Strain Reflects Ventriculoarterial Coupling Rather Than Mere Contractility in Rat Models of Hemodynamic Overload-Induced Heart Failure
Mihaly Ruppert et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2020)
Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure
Alex Ali Sayour et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cardiac sodium-dependent glucose cotransporter 1 is a novel mediator of ischaemia/reperfusion injury
Zhao Li et al.
CARDIOVASCULAR RESEARCH (2019)
Myofilament Ca2+ sensitivity correlates with left ventricular contractility during the progression of pressure overload-induced left ventricular myocardial hypertrophy in rats
Mihaly Ruppert et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
Acute canagliflozin treatment protects against in vivo myocardial ischemia-reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation
Alex Ali Sayour et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Role of SGLT1 in high glucose level-induced MMP-2 expression in human cardiac fibroblasts
Liping Meng et al.
MOLECULAR MEDICINE REPORTS (2018)
SGLT2 inhibitors: hypotheses on the mechanism of cardiovascular protection
Robert M. Bell et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Chronic Pressure Overload Induces Cardiac Hypertrophy and Fibrosis via Increases in SGLT1 and IL-18 Gene Expression in Mice
Naoko Matsushita et al.
INTERNATIONAL HEART JOURNAL (2018)
Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk
Sara B. Seidelmann et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Sodium-dependent glucose transporters (SGLT) in human ischemic heart: A new potential pharmacological target
Alessandra Di Franco et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart
Anne Van Steenbergen et al.
SCIENTIFIC REPORTS (2017)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Is AMPK the savior of the failing heart?
Ty T. Kim et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Intracellular Na+ Concentration ([Na+]i) Is Elevated in Diabetic Hearts Due to Enhanced Na+-Glucose Cotransport
Rebekah Lambert et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Localizations of Na+-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart
Ivana Vrhovac et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2015)
Transgenic Knockdown of Cardiac Sodium/Glucose Cotransporter 1 (SGLT1) Attenuates PRKAG2 Cardiomyopathy, Whereas Transgenic Overexpression of Cardiac SGLT1 Causes Pathologic Hypertrophy and Dysfunction in Mice
Mohun Ramratnam et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Isoproterenol instigates cardiomyocyte apoptosis and heart failure via AMPK inactivation-mediated endoplasmic reticulum stress
Xiao-Zhen Zhuo et al.
APOPTOSIS (2013)
NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1
Magali Balteau et al.
CARDIOVASCULAR RESEARCH (2011)
Extracellular Signal-Regulated Kinases 1 and 2 Regulate the Balance Between Eccentric and Concentric Cardiac Growth
Izhak Kehat et al.
CIRCULATION RESEARCH (2011)
Differential Cardiac Remodeling in Preload Versus Afterload
Karl Toischer et al.
CIRCULATION (2010)
Functional effects of glucose transporters in human ventricular myocardium
Dirk von Lewinski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy
Sanjay K. Banerjee et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart
Junya Kuroda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states
Sanjay K. Banerjee et al.
CARDIOVASCULAR RESEARCH (2009)
Metformin Prevents Progression of Heart Failure in Dogs Role of AMP-Activated Protein Kinase
Hideyuki Sasaki et al.
CIRCULATION (2009)
Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure
Xiao-Mei Li et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)
NAD(P)H oxidase 4 mediates transforming growth factor-β1-induced differentiation of cardiac fibroblasts into myofibroblasts
I Cucoranu et al.
CIRCULATION RESEARCH (2005)
Epidermal growth factor inhibits 14C-α-methyl-D-glucopyranoside uptake in renal proximal tubule cells:: Involvement of PLC/PKC, p44/42 MAPK, and cPLA2
HJ Han et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Signaling cascade of ANG II-induced inhibition of α-MG uptake in renal proximal tubule cells
HJ Han et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
分享论文
